When creating Taproot in 2016, our vision for the company was built upon an expectation that our young industry would over the next few years be experiencing:
-
Blurring boundaries between medicinal and recreational use.
-
Commoditization of markets with low barriers to entry.
-
Slow diffusion of product innovation and technology.
-
Continued scarcity of capital until Federal prohibition gets lifted.
-
Massive deregulation of international markets with a strong medical focus.
As a result, we felt that in order to be successful, we needed to:
-
Complement the traditional products for medical and recreational use with special health & wellness formulations for the growing number of low dosage, daily users.
-
Focus on jurisdictions with strict regulatory frameworks and limit exposure to the industrial agriculture dynamics of cultivation.
-
Create a network of partnerships & alliances with leading technology providers.
-
Prepare the company for the incorporation of institutional capital.
-
Participate in selected international markets.
WHERE WE HAVE COME SO FAR
-
The launch of a CBD heavy vape pen offering in Dec 2017
-
The closing of 1 M seed capital followed by 0,5 M Series A (without numbers)
-
The award of licenses in Nevada and the start of applications in Colombia and Nevada dispensary
